Fulltext

Limited effect of highly active antiretroviral therapy among HIV-positive injecting drug users on the population level

van Asten, Liselotte C. ; Boufassa, Faroudy ; Schiffer, Veronique ; Brettle, Raymond P. ; Robertson, J. Roy ; Aguado, Ildefonso Hernádez ; McMenamin, Jim ; Zangerle, Robert ; Fontanet, Arnaud ; Coutinho, Roel A. ; Prins, Maria

In: The European Journal of Public Health, 2003, vol. 13, no. 4, p. 347-349

Ajouter à la liste personnelle
    Titre
    • Limited effect of highly active antiretroviral therapy among HIV-positive injecting drug users on the population level
    Auteur
    • van Asten, Liselotte C.. Municipal Health Service, Division of Public Health and Environment, Amsterdam, The Netherlands
    • Boufassa, Faroudy. SEROCO study group, Inserm U 292, Hôpital de Bicêtre, Le Kremlin Bicêtre, France
    • Schiffer, Veronique. Division of Infectious Diseases, Geneva University Hospital, Geneva, Switzerland
    • Brettle, Raymond P.. Infectious Diseases Unit, Western General Hospital, Edinburgh, UK
    • Robertson, J. Roy. Edinburgh Drug Addiction Study, Muirhouse Medical Group, Edinburgh, UK
    • Aguado, Ildefonso Hernádez. On behalf of the Valencian HIV Seroconversion Study, Department of Public Health, Miguel Hernandez University, Alicante, Spain
    • McMenamin, Jim. Scottish Centre for Infection and Environmental Health, Ruchill Hospital, Glasgow, UK
    • Zangerle, Robert. AIDS Unit, University of Innsbruck, Innsbruck, Austria
    • Fontanet, Arnaud. Municipal Health Service, Division of Public Health and Environment, Amsterdam, The Netherlands
    • Coutinho, Roel A.. Municipal Health Service, Division of Public Health and Environment, Amsterdam, The Netherlands
    • Prins, Maria. Municipal Health Service, Division of Public Health and Environment, Amsterdam, The Netherlands
    Type de document
    • Postprint
    Langue
    • Anglais
    Publié dans
    • The European Journal of Public Health, 2003, vol. 13, no. 4, p. 347-349. Oxford University Press
    Autre version électronique
    Identifiant OAI-PMH
    • oai:doc.rero.ch:292403
    Summary
    There is evidence that HIV-positive injecting drug users benefit less than other risk groups from highly active antiretroviral therapy that has been available since 1996. In this multicentre European study the impact of the availability of highly active antiretroviral therapy on the progression rates to AIDS and death among injecting drug users with a documented date of HIV seroconversion is studied. After highly active antiretroviral therapy became available the risk of AIDS and death for injecting drug users decreased by 28% and 36%, which is less than has been reported for other risk groups